Detalhe da pesquisa
1.
Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma.
Clin Chem
; 70(3): 516-527, 2024 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300881
2.
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab).
Cancer Immunol Immunother
; 70(6): 1781-1788, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33196890
3.
Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB-IV M1c melanoma patients.
Cancer Immunol Immunother
; 69(5): 759-769, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32052079
4.
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma.
Pigment Cell Melanoma Res
; 37(2): 309-315, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975535
5.
Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report.
Front Immunol
; 15: 1342845, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38571955
6.
Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab - a case report.
Front Immunol
; 14: 1324231, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38143738
7.
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.
Clin Epigenetics
; 15(1): 112, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37415208
8.
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy.
Clin Epigenetics
; 14(1): 50, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410311
9.
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
EBioMedicine
; 52: 102647, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32028068
10.
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
EBioMedicine
; 59: 102962, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32861198